Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: Non-histone chromosomal proteins, HMG1 and HMG2

Clinical and Experimental Immunology

Volumn 107, Issue 1, 1997, Pages 135-140

  Sobajima, J ^a   Ozaki, S ^a   Osakada, F ^a   Uesugi, H ^a   Shirakawa, H ^b   Yoshida, M ^b   Nakao, K ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

ANCA; HMG1 and HMG2

Indexed keywords

AUTOANTIGEN; GRANULOCYTE ANTIBODY; NONHISTONE PROTEIN; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; NEUTROPHIL; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0031024347     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-907.x     Document Type: Article

References (31)

1. Wieslander J. How are antineutrophil cytoplasmic autoantibodies detected? The Third International Workshop on Antineutrophil Cytoplasmic Autoantihodies. Am J Kidney Dis 1991; 18:154-8.
2. Saxon A, Shanahan F, Landers C et al. A distinct subset of anti-neutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990; 86:202-10.
3. Duerr RH, Targan SR, Landers CJ et al. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis: comparison with other colitides/ diarrheal illnesses. Gastroenterology 1991; 100:1590-6.
4. Seibold F, Weber P, Klein R et al. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992; 33:657-62.
5. Cambridge G, Rampton DS, Stevens TRJ et al. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1992; 33:668-74.
6. Falk RJ, Sartor RB, Jones DA et al. Anti-neutrophil cytoplasmic autoantibodies (ANCA) in ulcerative colitis (UC). Clin Res 1990; 38:387 (Abstr.).
7. Halbwachs-Mecarelli L, Nushaum P, Noël LH et al. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1992; 90:79-84.
8. Peen E, Almer S, Bodemar G et al. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. Gut 1993; 34:56-62.
9. Sobajima J, Ozaki S, Okazaki T et al. Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with refractory type. Clin Exp Immunol 1996; 105:120-5.
10. Yoshida M, Shimura K. Unwinding of DNA by nonhistone chromosomal protein HMG (1+2) from pig thymus as determined with endonuclease. J Biochem 1984; 95:117-24.
11. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
12. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. Acta Pathol Microbiol Immunol Scand 1989; 97:12-13.
13. Charles LA, Falk RJ, Jennette JC. Reactivity of anti-neutrophil cytoplasmic autoantibodies with HL-60 cells. Clin Immunol Immunopathol 1989; 53:243-53.
14. Altschul SF, Gish W, Miller W et al. Basic local alignment search tool. J Mol Biol 1990; 215:403-10.
15. Majumdar A, Brown D, Kerby S et al. Sequence of human HMG2 cDNA. Nucleic Acids Res 1991; 19:6643.
16. Wen L, Huang JK, Johnson BH et al. A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1. Nucleic Acids Res 1989; 17:1197-214.
17. Shirakawa H, Yoshida M. Structure of a gene coding for human HMG2 protein. J Biol Chem 1992; 267:6641-5.
18. Shirakawa H, Tsuda K, Yoshida M. Primary structure of non-histone chromosomal protein HMG2 revealed by the nucleotide sequence. Biochemistry 1990; 29:4419-23.
19. Bustin M, Lehn DA, Landsman D. Structural features of the HMG chromosomal proteins and their genes. Biochim Biophys Acta 1990; 1049:231-43.
20. Jennette JC, Wilkman AS, Falk RJ. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 1989; 135:921-30.
21. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318:1651-7.
22. Bustin M, Reish J, Einck L. Autoantibodies to nucleosomal proteins: antibodies to HMG-17 in autoimmune diseases. Science 1982; 215:1245-7.
23. Wittemann B, Neuer G. Michels H et al. Autoantibodies to nonhistone chromosomal proteins HMG-1 and HMG-2 in sera of patients with juvenile rheumatoid arthritis. Arthritis Rheum 1990; 33:1378-83.
24. Craft J, Hardin JA. Antinuclear antibodies. In: Kelley WN, Harris ED, Ruddy S et al., eds. Textbook of rheumatology, 4th edn, Philadelphia: W.B. Saunders Co., 1993:164-87.
25. Einck L, Bustin M. The intracellular distribution and function of the high mobility group chromosomal proteins. Exp Cell Res 1985; 156:295-310.
26. Bustin M, Neihart NK. Antibodies against chromosomal HMG proteins stain the cytoplasm of mammalian cells. Cell 1979; 16: 181-9.
27. Bidney DL, Reeck GR. Purification from cultured hepatoma cells of two nonhistone chromatin proteins with preferential affinity for single-stranded DNA: apparent analogy with calf thymus HMG proteins. Biochem Biophys Res Commun 1978; 85:1211-8.
28. Aizawa S, Nishino H, Saito K et al. Stimulation of transcription in cultured cells by high mobility group protein 1: essential role of the acidic carboxyl-terminal region. Biochemistry 1994; 33:14690-5.
29. Ogawa Y, Aizawa S, Shirakawa H et al. Stimulation of transcription accompanying relaxation of chromatin structure in cells overexpressing high mobility group 1 protein. J Biol Chem 1995; 270:9272-80.
30. Seyedin SM, Kistler WS. Levels of chromosomal protein high mobility group 2 parallel the proliferate activity of testis, skeletal muscle, and other organs. J Biol Chem 1979; 254:11264-71.
31. Yamazaki F, Nagatsuka Y, Shirakawa H et al. Repression of cell cycle progression by antisense HMG2 RNA. Biochem Biophys Res Commun 1995; 210:1045-51.